Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sari Roth-Roemer"'
Publikováno v:
Archives of Clinical Neuropsychology. 37:1346-1346
Objective: Return to driving (RTD) following an acquired brain injury (ABI) positively impacts an individual’s productivity, quality of life, and community re-integration. Research illustrates that the return to driving is a complex process influen
Autor:
Sureyya Dikmen, Samantha B. Artherholt, Jo Ann Broeckel Elrod, Sari Roth-Roemer, Shelby L. Langer, Brenda F. Kurland, Karen L. Syrjala
Publikováno v:
Journal of Clinical Oncology. 29:2397-2404
Purpose Research has documented cognitive deficits both before and after high-dose treatment followed by allogeneic hematopoietic cell transplantation (HCT), with partial recovery by 1 year. This study prospectively examined the trajectory and extent
Autor:
Thomas Zaubler, Jesse R. Fann, Sari Roth-Roemer, Wayne J. Katon, Rami Bustami, Karen L. Syrjala
Publikováno v:
Psychosomatics. 51:320-329
Publikováno v:
Journal of Clinical Oncology. 25:1223-1231
Purpose To determine the impact of delirium during the acute phase of myeloablative hematopoietic stem-cell transplantation (HSCT) on health-related quality of life (HRQOL), distress, and neurocognitive functioning 30 and 80 days after transplantatio
Autor:
Sari Roth-Roemer, Bart E. Burington, Wayne J. Katon, Karen L. Syrjala, Catherine M. Alfano, M.P.H. Jesse R. Fann M.D.
Publikováno v:
Cancer. 103:810-820
BACKGROUND Delirium is common in patients undergoing hematopoietic stem cell transplantation (HSCT) and is associated with considerable morbidity and excess mortality in diverse patient samples. Although delirium can be treated successfully, it is la
Publikováno v:
Blood. 104:3386-3392
Research indicates that myeloablative hematopoietic cell transplantation (HCT) impairs neurocognitive function. However, prospective studies on long-term effects are lacking. This longitudinal study examined neurocognitive changes over the first year
Autor:
Wayne J. Katon, M.P.H. Jesse R. Fann M.D., Sari Roth-Roemer, Karen L. Syrjala, Bart E. Burington
Publikováno v:
Cancer. 95:1971-1981
BACKGROUND Delirium is common in patients with malignant disease and is associated with significant morbidity. Studies have not examined the epidemiology of delirium in patients undergoing hematopoietic stem cell transplantation (HSCT). The objective
Autor:
Wayne Katon, Rebecca A. Hubbard, Karen L. Syrjala, Catherine M. Alfano, Sari Roth-Roemer, Jesse R. Fann
Purpose To determine pre- and post-transplantation risk factors for delirium onset and severity during the acute phase of myeloablative hematopoietic stem-cell transplantation (HSCT). Patients and Methods Ninety adult patients with malignancies admit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e470536aff55648b893e79132e7651
https://europepmc.org/articles/PMC3068062/
https://europepmc.org/articles/PMC3068062/
Publikováno v:
Journal of Pain and Symptom Management. 13:125-127
Delirium is one of the most c o m m o n neur o p s y c h i a t r i c d i s o r d e r s in m e d i c a l l y ill patients, and is est imated to occur in 10%35% of hospitalized inpatients. 1'2 It is associa ted with significantly increased morbidity, m
Autor:
Jesse R, Fann, Catherine M, Alfano, Bart E, Burington, Sari, Roth-Roemer, Wayne J, Katon, Karen L, Syrjala
Publikováno v:
Cancer. 103(4)
Delirium is common in patients undergoing hematopoietic stem cell transplantation (HSCT) and is associated with considerable morbidity and excess mortality in diverse patient samples. Although delirium can be treated successfully, it is largely undia